10x Genomics, Inc. (TXG): Total Liabilities
$245.04M
As of 2025-12-31
$204.52M
As of 2026-06-30
+3.2%
3-year compound annual growth
+5.2%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $245.04M | +17.5% | 2026-02-13, Balance as of period end |
| 2024-12-31 | $208.50M | -7.0% | 2026-02-13, Balance as of period end |
| 2023-12-31 | $224.10M | +0.4% | 2025-02-13, Balance as of period end |
| 2022-12-31 | $223.24M | +10.9% | 2024-02-15, Balance as of period end |
| 2021-12-31 | $201.26M | +5.8% | 2023-02-16, Balance as of period end |
| 2020-12-31 | $190.27M | +2.4% | 2022-02-18, Balance as of period end |
| 2019-12-31 | $185.84M | +83.9% | 2021-02-26, Balance as of period end |
| 2018-12-31 | $101.05M | n/a | 2020-02-27, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| 10x Genomics, Inc. (TXG) | 2025-12-31 | $245.04M | +17.5% |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | $119.80M | +15.5% |
| Pacific Biosciences of California, Inc. (PACB) | 2025-12-31 | $778.73M | +3.3% |
| Bio-Rad Laboratories, Inc. (BIO) | 2025-12-31 | $3.12B | +11.7% |
| Revvity, Inc. (RVTY) | 2025-12-28 | $4.92B | +4.1% |
| Quanterix Corp (QTRX) | 2025-12-31 | $123.04M | +60.8% |
| Waters Corp (WAT) | 2025-12-31 | $2.52B | -7.7% |
| Bruker Corp (BRKR) | 2025-12-31 | $3.73B | -6.5% |
| Mettler Toledo International Inc (MTD) | 2025-12-31 | $3.74B | +11.0% |
Compare TXG, CTKB, PACB, BIO side by side · Screen every company in Laboratory Analytical Instruments ↗